Multiple Cancer Early Detection (MCED) and evolving Scenarios of Cancer Screening
Tracks
| Thursday, June 19, 2025 |
| 8:30 - 10:00 |
| Centralvaerkstedet, Plenary Conference Room |
Overview
Plenary Session
Details
Programme Outline:
08:30 – 09:00 Framework of Elements to consider when evaluating MCED, Nereo Segnan
09:00 – 09:30 NHS-Galleri Trial and beyond, Peter Sasieni
09:30 – 10:00 Panel Discussion
Panel Discussion:
In this discussion, we will explore potential future scenarios for the use of MCED. Could MCED become a viable strategy for cancer screening? Might it replace or complement existing single-cancer screening programmes? What are the potential benefits, challenges, and risks associated with MCED? And what kind of evidence and evaluation will be required before its implementation can be considered?
Speaker(s)
Dr Nereo Segnan
Founder
Center For Cancer Epidemiology And Prevention In Piedmont (cpo)
Framework of Elements to consider when evaluating MCED
Biography
Nereo Segnan has made significant contributions to cancer prevention and screening. Since 2003, he has been the principal investigator of several large RCTs, including SCORe, SCORe 2, and SCORe 3, focusing on colorectal cancer screening. He also led the Department of Cancer Screening at Città della Salute e della Scienza University Hospital in Turin from 2008 to 2017. Additionally, he has been involved in European Commission-funded projects on cancer screening quality assurance and health technology assessment. Since 2012, he served as a Senior Visiting Scientist at IARC in Lyon, further advancing global cancer research and prevention strategies.
Peter Sasieni
Queen Mary University of London
NHS-Galleri Trial and beyond
Biography
Chair(s)
Berit Andersen
Professor, Head og Department
Randers Regional Hospital
Harry De Koning
Professor Of Public Health And Screening Evaluation Deputy Head
Erasmus Medical Center Rotterdam
Discussants
Claus Lindbjerg Andersen
Aarhus University
Ruth Etzioni
Professor
Fred Hutchinson Cancer Center
Peter Sasieni
Queen Mary University of London
Nereo Segnan
Founder
Center For Cancer Epidemiology And Prevention In Piedmont (cpo)
Robert Smith
Sr Vp, Cancer Screening, And Director, Center For Early Cancer Detection Science
American Cancer Society
